world
wit
unpreced
human
econom
loss
diseas
caus
novel
coronaviru
extens
research
conduct
across
globe
identifi
therapeut
agent
use
power
effici
comput
strategi
combin
machin
learn
ml
base
model
highfidel
ensembl
dock
simul
enabl
rapid
screen
possibl
therapeut
molecul
ligand
screen
base
bind
affin
either
isol
sprotein
host
receptor
region
sproteinhuman
interfac
complex
therebi
potenti
limit
andor
disrupt
hostviru
interact
first
appli
screen
strategi
two
drug
dataset
cureffi
drugcentr
identifi
hundr
ligand
bind
strongli
aforement
two
system
candid
ligand
valid
atom
dock
simul
valid
ml
model
subsequ
use
screen
larg
biomolecul
dataset
nearli
million
entri
provid
rankord
list
potenti
use
compound
valid
overal
work
expand
knowledg
smallmolecul
treatment
also
provid
effici
pathway
perform
highthroughput
comput
drug
screen
combin
quick
ml
surrog
model
expens
highfidel
simul
acceler
therapeut
cure
diseas
march
world
health
organ
declar
novel
coronaviru
diseas
pandem
million
peopl
across
countri
alreadi
affect
diseas
live
lost
global
april
addit
daili
live
million
peopl
impact
mandatori
lockdown
observ
across
world
let
alon
econom
cost
advers
diseas
caus
new
coronaviru
belong
sar
famili
sarscov
alreadi
sequenc
sever
studi
focus
understand
interact
human
cell
receptor
ongo
screen
smallmolecul
biomolecul
potenti
therapeut
abil
also
conduct
use
theoret
machin
learn
method
initi
report
previou
work
gener
sar
coronaviru
suggest
close
interact
viral
spike
protein
sprotein
coronaviru
specif
human
host
receptor
angiotensinconvert
enzym
receptor
hypothes
compound
reduc
interact
sprotein
receptor
could
limit
viral
recognit
host
human
cell
andor
disrupt
hostviru
interact
end
smith
et
al
recent
conduct
virtual
highthroughput
screen
nearli
smallmolecul
bind
strongli
either
isol
sprotein
host
receptor
region
thu
hinder
viral
recognit
host
cell
sprotein
human
receptor
interfac
thu
reduc
hostviru
interact
success
identifi
ligand
regulatori
approv
food
drug
administr
fda
similar
agenc
satisfi
one
two
criteria
despit
vast
chemic
space
million
billion
biomolecul
potenti
explor
sever
limit
number
candid
compound
nearli
consid
work
owe
high
comput
cost
ensembl
dock
simul
employ
methodolog
build
exemplari
work
smith
et
al
use
data
set
gener
autodockingmolecular
model
train
valid
machin
learn
ml
model
allow
us
significantli
expand
search
space
screen
million
potenti
therapeut
agent
use
bind
affin
vina
score
ligand
sprotein
interfac
complex
isol
sprotein
screen
criteria
identifi
promis
candid
use
ml
model
ml
model
appli
two
drug
dataset
name
cureffi
drugcentr
contain
ligand
present
known
drug
respect
also
deploy
ml
model
rapidli
screen
huge
bindingdb
dataset
contain
million
small
biomolecul
identifi
candid
bind
strongli
either
isol
sprotein
sprotein
human
receptor
interfac
complex
screen
workflow
adopt
work
present
figur
illustr
interfac
coronaviru
receptor
present
figur
work
base
combin
ml
method
ensembl
dock
simul
screen
promis
ligand
two
independ
random
forest
rf
regress
model
train
quickli
estim
vina
score
given
candid
drug
molecul
ligand
isol
sprotein
sprotein
human
receptor
interfac
use
dataset
provid
smith
et
al
vina
score
hybrid
empir
knowledgebas
score
function
rank
molecular
conform
predict
free
energi
bind
base
intermolecular
contribut
eg
steric
hydrophob
hydrogen
bond
etc
set
hierarch
descriptor
featuresfingerprint
captur
differ
geometr
chemic
inform
multipl
lengthscal
atom
morpholog
use
repres
molecul
success
applic
ml
model
model
valid
monitor
perform
valid
set
ensembl
dock
simul
hundr
promis
candid
ligand
overal
identifi
sever
hundr
new
ligand
candid
potenti
therapeut
abil
fda
approv
list
biomolecul
bindingdb
dataset
satisfi
screen
criteria
also
provid
use
develop
ml
model
base
featur
import
reveal
ml
model
also
provid
analysi
key
chemic
trend
common
across
identifi
promis
candid
note
work
expand
knowledg
potenti
smallmolecul
treatment
also
provid
power
effici
pathway
ie
train
ml
result
comput
expens
simul
use
ml
cast
wider
net
downselect
follow
target
comput
simul
final
chemic
guidelin
acceler
therapeut
cure
diseas
depict
figur
start
dataset
vina
score
small
molecul
sprotein
sprotein
interfac
first
fingerprint
molecul
use
smile
represent
fingerprint
procedur
discuss
detail
obtain
molecular
descriptor
along
respect
vina
score
use
train
two
independ
random
forest
ml
model
properti
ml
model
next
use
make
vina
score
predict
fda
approv
drug
cureffi
databas
drug
drugcentr
databas
candid
ligand
significantli
low
vina
score
predict
high
bind
affin
sprotein
sprotein
interfac
system
screen
valid
use
ensembl
dock
simul
ml
predict
found
good
agreement
expens
dock
simul
thu
valid
develop
ml
model
accur
vina
score
predict
identifi
sever
ten
new
fda
approv
otherwis
ligand
high
bind
affin
sprotein
sprotein
interfac
ml
model
valid
appli
extens
small
biomolecul
dataset
ie
bindingdb
million
entri
screen
mani
potenti
candid
discuss
detail
train
set
molecular
descriptor
random
forest
algorithm
use
develop
ml
model
two
train
dataset
obtain
smith
et
al
one
correspond
vina
score
molecul
sprotein
sprotein
interfac
complex
dataset
contain
molecul
sweetlead
databas
along
smile
represent
use
input
fingerprint
algorithm
mani
molecul
vina
score
report
extrem
high
much
kcalmol
favor
bind
energet
vina
score
roughli
kcalmol
rang
remov
skew
data
train
model
gear
toward
identifi
favor
molecul
lower
vina
score
data
point
neg
vina
score
consid
studi
case
smile
represent
could
resolv
correctli
filter
overal
result
data
point
origin
number
sprotein
interfac
isol
sprotein
system
respect
henceforth
refer
clean
dataset
smith
dataset
build
accur
reliabl
ml
model
import
includ
relev
featur
collect
captur
trend
vina
score
differ
molecul
toward
sprotein
sprotein
interfac
complex
featur
uniqu
repres
molecul
readili
avail
new
case
base
past
experi
fingerprint
organ
materi
includ
polym
three
hierarch
level
featur
consid
captur
differ
geometr
chemic
inform
ligand
multipl
lengthscal
atom
scale
count
predefin
set
motif
includ
motif
specifi
gener
label
b
j
c
k
repres
ifold
coordin
atom
jfold
coordin
b
atom
kfold
coordin
c
atom
connect
specifi
order
exampl
repres
threefold
coordin
n
threefold
coordin
carbon
fourfold
coordin
carbon
slightli
larger
lengthscal
quantit
structureproperti
relationship
qspr
descriptor
often
use
chemic
biolog
scienc
implement
rdkit
python
librari
use
lastli
highest
lengthscal
morpholog
descriptor
length
largest
sidechain
shortest
topolog
distanc
ring
etc
consid
detail
differ
hierarch
descriptor
found
previou
work
random
forest
rf
regress
algorithm
implement
scikitlearn
python
packag
use
train
two
vina
score
model
sprotein
sprotein
interfac
use
smith
dataset
rf
ensembl
decis
tree
averag
predict
larg
group
weak
model
overal
result
better
predict
fall
umbrella
ensembl
method
often
win
solut
machin
learn
competit
rf
hyperparamet
ie
number
weak
estim
estim
maxim
valid
error
crossvalid
cv
lead
better
gener
model
avoid
overfit
perform
ml
model
evalu
use
root
mean
squar
error
rmse
mean
absolut
error
mae
correl
coeffici
r
estim
predict
error
unseen
data
learn
curv
gener
vari
size
train
test
set
result
includ
supplementari
inform
si
learn
curv
test
set
obtain
exclud
train
point
smith
dataset
addit
random
testtrain
split
statist
meaning
result
obtain
averag
run
final
ml
model
use
predict
cureffi
drugcentr
bindingdb
dataset
train
entir
smith
dataset
use
cv
consist
estim
isol
sprotein
sprotein
interfac
dataset
respect
valid
ml
model
perform
dock
calcul
top
candid
identifi
model
base
low
vina
score
inlin
work
smith
et
al
use
autodock
vina
softwar
comput
bind
affin
top
candid
sprotein
complex
structur
sprotein
ncbi
refer
sequenc
receptor
protein
data
bank
id
detail
regard
construct
model
sprotein
complex
describ
sprotein
necessari
mutat
predecessor
sar
varieti
sarscov
name
l
f
q
n
respect
illustr
figur
smith
et
al
focus
bind
pocket
region
evalu
bind
affin
differ
molecul
sweetlead
librari
discuss
earlier
follow
procedur
describ
smith
et
al
also
rankord
top
candid
base
vina
score
correl
free
energi
bind
sprotein
dock
receptor
obtain
smith
et
al
consist
six
conform
sprotein
interfac
well
isol
sprotein
receptor
ie
receptor
remov
sampl
use
root
mean
squar
displac
rmsd
base
cluster
microsecond
long
allatom
temperatur
replica
exchang
gromac
simul
sprotein
complex
water
dock
ligand
prepar
smile
string
candid
use
open
babel
softwar
setup
dock
calcul
similar
describ
smith
et
al
defin
nm
nm
nm
search
space
encompass
bind
pocket
locat
sprotein
interfac
shown
figur
search
space
explor
isol
sprotein
receptor
case
well
candid
dock
procedur
find
top
optim
dock
configur
select
one
best
vina
score
describ
detail
candid
identifi
ml
model
obtain
drugcentr
databas
well
fda
approv
cureffi
databas
smith
dataset
use
train
valid
ml
model
three
addit
drug
dataset
use
make
predict
identifi
ligand
candid
show
high
bind
affin
viral
sprotein
sprotein
interfac
includ
fda
approv
cureffi
dataset
dataset
common
activ
ingredi
drugcentr
bindingdb
dataset
small
molecul
smile
represent
molecul
obtain
dataset
unprocess
candid
remov
result
entri
respect
cureffi
dataset
consist
ligand
approv
fda
specif
contain
central
nervou
system
drug
drug
list
pars
epa
environment
protect
agenc
suit
appropri
curat
drugcentr
openaccess
onlin
drug
compendium
integr
structur
bioactiv
regulatori
pharmacolog
action
indic
activ
pharmaceut
ingredi
approv
fda
regulatori
agenc
bindingdb
databas
publicli
access
base
measur
bind
affin
druglik
molecul
interact
variou
protein
target
consist
million
entri
bind
data
molecul
dataset
first
two
dataset
exclus
use
valid
ml
model
dock
simul
bindingdb
dataset
use
ml
predict
chemic
accuraci
kcalmol
believ
ml
model
accept
screen
purpos
even
sprotein
model
rel
lower
error
observ
case
low
vina
score
particularli
relev
studi
see
si
detail
valid
ml
model
use
learn
curv
includ
error
converg
studi
train
test
set
result
clearli
indic
develop
surrog
ml
model
could
use
quickli
screen
new
ligand
candid
low
sprotein
sprotein
interfac
vina
score
without
exclus
perform
comput
demand
dock
simul
end
use
ml
model
make
predict
fda
approv
activ
ingredi
cureffi
dataset
ligand
drugcentr
dataset
present
figur
c
sinc
true
vina
score
ligand
known
show
ml
predict
hypothes
ligand
could
effect
coronaviru
either
form
sprotein
interfaceligand
bind
complex
low
sprotein
vina
score
disrupt
hostviru
interact
bind
receptor
recognit
region
sprotein
low
sprotein
vina
score
reduc
viral
recognit
host
thu
defin
simpl
screen
criteria
select
top
candid
low
vina
score
account
dash
line
figur
c
depict
chosen
screen
criteria
given
equat
x
x
repres
vina
score
sprotein
interfaceligand
complex
sproteinligand
system
respect
candid
score
lower
screen
valid
note
ligand
select
next
ensembl
dock
simul
perform
select
drug
candid
result
present
figur
comparison
result
smith
dataset
also
includ
purpos
simul
threefold
first
accur
estim
vina
score
obtain
highfidel
comput
identifi
promis
candid
second
provid
new
data
point
valid
ml
model
lastli
common
candid
ligand
common
top
list
smith
help
us
valid
simul
simul
perform
smith
paper
figur
evid
ml
model
inde
help
us
screen
candid
favor
vina
score
almost
screen
candid
seen
ml
screen
criteria
line
dash
line
identifi
candid
found
vina
score
greater
show
bind
affin
sprotein
interfac
complexsuch
case
rel
much
higher
vina
score
exclud
plot
better
readabl
thu
screen
candid
inde
favor
comparison
smith
et
al
expens
dock
simul
larg
set
candid
mani
fall
outsid
screen
boundari
captur
effici
procedur
adopt
ie
use
cheap
surrog
model
quick
screen
follow
expens
highfidel
dock
simul
valid
also
provid
valid
predict
accuraci
develop
ml
model
pariti
plot
directli
compar
vina
score
predict
ml
model
respect
dock
simul
result
also
provid
si
exampl
illustr
sprotein
interfaceligand
complex
top
candid
also
includ
si
importantli
train
ml
model
predict
sever
ligand
includ
sever
fda
approv
activ
ingredi
favor
vina
score
top
among
candid
present
figur
complet
list
candid
along
respect
vina
score
provid
si
top
fda
approv
ligand
candid
includ
pemirolast
inn
mast
cell
stabil
use
antiallerg
drug
therapi
market
tradenam
alegys
alamast
sulfamethoxazol
smz
smx
anoth
fda
approv
ligand
antibiot
use
bacteri
infect
urinari
tract
infect
bronchiti
prostat
valaciclovir
anoth
top
candid
identifi
screen
antivir
drug
use
treat
herp
viru
infect
includ
shingl
cold
sore
genit
herp
chickenpox
sulfanilamid
use
typic
antibacteri
agent
treat
bronchiti
prostat
urinari
tract
infect
tzaobactum
anoth
fda
approv
antibiot
typic
combin
piperacillin
treat
antibacteri
infect
cellul
diabet
foot
infect
append
postpartum
endometr
infect
nitrofurantoin
also
antibiot
use
treat
urinari
tract
infect
amongst
nonfda
approv
ligand
find
top
candid
protirelin
synthet
analogu
endogen
peptid
thyrotropinreleas
hormon
trh
benserazid
also
call
serazid
anoth
top
ligand
peripher
act
aromat
lamino
acid
decarboxylas
dopa
decarboxylas
inhibitor
use
parkinson
diseas
top
candid
includ
sulfaperin
sulfaperin
sulfonamid
antibacteri
agent
succinylsulfathiazol
sulfonamid
use
intestin
bacteriostat
agent
interestingli
one
top
candid
emerg
screen
uridin
triphosph
utp
nucleotid
triphosph
sourc
energi
activ
substrat
metabol
reaction
addit
bind
energi
one
also
use
thermodynam
criteria
screen
ligand
candid
instanc
although
bind
energi
ligand
primari
criterion
relat
bind
affin
measur
autodock
simul
base
free
energi
metric
develop
lipinski
cowork
also
certain
implic
efficaci
drug
could
use
screen
identifi
candid
ligand
like
poor
absorpt
noctanolwat
partit
coeffici
log
p
molecular
weight
mw
number
hbond
donor
number
hbond
acceptor
figur
show
log
p
top
candid
identifi
base
lowest
valu
vina
score
cureffi
drugcentr
databas
top
ligand
seen
log
p
consist
lipinski
rule
five
molecular
weight
compound
lower
da
provid
si
along
properti
henri
constant
number
hydrogen
bond
acceptor
donor
henri
constant
log
h
anoth
import
properti
measur
solubl
compound
water
drug
uptaken
cellular
membran
desir
drug
solubl
water
neg
henri
constant
solubl
drug
aqueou
phase
howev
balanc
desir
partit
membran
aqueou
phase
gener
sought
thu
present
tabl
identifi
top
candid
continu
satisfi
addit
criteria
importantli
note
constraint
introduc
futur
work
screen
desir
candid
ligand
instanc
molecul
log
p
known
high
affin
toward
aqueou
media
poorli
absorb
lipid
bilay
cellular
membran
mani
top
candid
seen
fall
categori
eg
amilorid
log
p
water
friendli
use
waterpillsdiuret
nitrofurantoin
log
p
use
treat
urinari
tract
infect
beyond
serv
comput
effici
altern
drug
dock
simul
learnt
ml
model
also
util
mine
import
chemic
trend
extract
simpl
chemic
rule
data
regard
develop
rf
model
use
identifi
import
featuresdescriptor
util
work
rf
rel
import
featur
defin
use
rel
rank
depth
featur
use
decis
node
tree
sinc
featur
use
top
tree
contribut
toward
final
predict
larger
fraction
input
sampl
base
philosophi
provid
list
top
featur
found
relev
sprotein
sprotein
interfac
model
si
importantli
found
n
score
molecul
well
pearson
correl
coeffici
r
correl
sprotein
vina
score
higher
n
score
lower
vina
score
molecul
sprotein
complex
varieti
molecular
quantum
number
mqn
also
found
highli
relevantthos
captur
number
member
ring
topolog
surfac
area
cyclic
trival
tetraval
node
node
edg
share
ring
count
aliphat
ring
also
among
import
descriptor
valid
ml
model
significantli
expand
search
space
candid
molecul
made
predict
roughli
million
molecul
bindingdb
dataset
vina
score
predict
present
figur
nearli
molecul
found
satisfi
earlier
chosen
screen
criteria
see
si
complet
list
exemplari
case
illustr
figur
b
result
clearli
demonstr
power
effici
use
surrog
model
preliminari
screen
instanc
dock
simul
identifi
candid
activ
ingredi
complet
period
around
day
contrast
vina
score
predict
ml
model
entir
bindingdb
dataset
obtain
within
day
use
similar
comput
resourc
includ
time
requir
fingerprint
make
model
predict
evid
ml
strategi
effici
abl
screen
million
candid
biomolecul
make
use
suggest
aid
decis
make
process
expert
biologist
medic
profession
robust
highfidel
comput
follow
synthesi
trial
experi
perform
confirm
valid
select
molecul
amongst
screen
nonfda
biomolecul
top
candid
includ
fidarestat
aldos
reductas
inhibitor
investig
treatment
diabet
neuropathi
quercetin
plant
flavonol
flavonoid
group
polyphenol
also
display
high
vina
score
amongst
screen
candid
top
candid
includ
myricetin
member
flavonoid
class
polyphenol
compound
antioxid
properti
scolumbianetin
use
antiinflammatori
indirubin
antiinflammatori
antiangiogenesi
properti
vitro
cupressuflavon
antiinflammatori
analges
properti
conclus
present
effici
virtual
screen
strategi
identifi
ligand
potenti
limit
andor
disrupt
hostviru
interact
hypothesi
ligand
bind
strongli
isol
sprotein
host
human
receptor
region
sproteinhuman
interfac
complex
like
effect
highthroughput
screen
strategi
base
use
combin
machin
learn
ml
highfidel
dock
simul
identifi
candid
display
high
bind
affin
first
train
ml
result
comput
expens
simul
subsequ
use
valid
ml
search
much
larger
chemic
space
fda
approv
ligand
subsequ
biomolecul
downselect
base
ml
predict
vina
score
final
mine
chemic
guidelin
acceler
therapeut
cure
diseas
two
random
forest
model
train
quickli
predict
vina
score
molecul
isol
sprotein
sprotein
human
interfac
complex
use
dataset
past
work
train
ml
model
comprehens
set
chemic
featur
compil
base
past
experi
fingerprint
organ
materi
captur
geometr
chemic
inform
ligand
multipl
lengthscal
ml
model
first
use
screen
ligand
two
drug
dataset
cureffi
drugcentr
inde
found
bind
strongli
isol
sprotein
sproteinhuman
interfac
complex
use
expens
autodock
simul
valid
accuraci
ml
model
develop
also
help
identifi
promis
fda
approv
ligand
mani
identifi
top
ligand
also
found
satisfi
lipinski
rule
five
ml
model
valid
use
screen
candid
larg
dataset
biomolecul
million
bindingdb
dataset
rankord
list
promis
candid
differ
dataset
provid
theoret
experiment
valid
